Abrdn PLC Bio N Tech Se Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Bio N Tech Se stock. As of the latest transaction made, Abrdn PLC holds 721,928 shares of BNTX stock, worth $80.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

721,928

Previous 385,668 87.19%

Holding current value

$80.4 Million

Previous $35.1 Million 118.87%

% of portfolio

0.13%

Previous 0.07%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$86.65 - $120.54 $29.1 Million - $40.5 Million	336,260 Added 87.19%	721,928 $76.9 Million
Q4 2024 Jan 24, 2025	BUY	$99.72 - $122.68 $15.9 Million - $19.6 Million	159,676 Added 70.66%	385,668 $43.9 Million
Q3 2024 Oct 24, 2024	BUY	$78.36 - $124.66 $13.6 Million - $21.7 Million	173,969 Added 334.41%	225,992 $26.8 Million
Q2 2024 Aug 09, 2024	SELL	$80.36 - $102.87 $4.17 Million - $5.33 Million	-51,835 Reduced 49.91%	52,023 $4.18 Million
Q4 2023 Jan 31, 2024	BUY	$90.91 - $112.75 $9.44 Million - $11.7 Million	103,858 New	103,858 $11 Million

Others Institutions Holding BNTX

# of Institutions

343

Shares Held

40.3M

Call Options Held

1.55M

Put Options Held

1.46M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account